When participants were stratified into four groups based on their relative chemerin and adiponectin levels, participants in the high chemerin/low adiponectin group showed significantly higher triglyceride levels and a greater incidence of MetS than other three groups, after adjusting for age, gender, and adiposity. This evidence concerns the gene ADIPOQ and metabolic syndrome.